Second-generation antipsychotics (SGAs) are no better than placebo from a cost-benefit viewpoint for treating psychosis and aggression in Alzheimer disease patients, according to a report in the November issue of the Archives of General Psychiatry. Reuters Health Information
Lung abnormalities are seen in a significant minority of patients after dasatinib treatment for chronic myeloid leukemia, according to a case series compiled by French investigators. Reuters Health Information
Administration of the selective estrogen receptor modulator (SERM) toremifene has beneficial effects on the hypothalamic-pituitary-testicular axis and sperm parameters in men with idiopathic oligozoospermia, according to Greek researchers. Reuters Health Information
While the use of cardiovascular medications after myocardial infarction (MI) is inadequate, it has increased over time, according to findings published in the October issue of the American Journal of Cardiology. However, statins and beta-blockers continue to be markedly underused in black patients. Reuters Health Information
Two U.S. lawmakers said on Tuesday they want to interview a former GlaxoSmithKline official as they probe whether a prominent diabetes doctor was pressured by the company for criticizing its drug Avandia. Reuters Health Information
A meta-analysis of randomized trials shows modest weight reduction for orlistat, sibutramine, and rimonabant, with differing effects on cardiovascular risk profiles and specific adverse effects. Medscape Medical News
A new analysis of an atrial fibrillation trial shows that patients with paroxysmal atrial fibrillation have similar risks for stroke and embolism as those with sustained atrial fibrillation. Medscape Medical News
The Food and Drug Administration has approved a new indication for rosuvastatin to slow the progression of atherosclerosis in patients with elevated cholesterol. Medscape Medical News
